semaglutide for heart health disease: may reduce risk by up to 20% in 6 months GLP-1 drugs and healthy habits

Moving from peptide-based biologics to small molecules like orforglipron redefines scalability, simplifies supply chains, and expands global reach

Key Findings 93.4% of patients would get bariatric surgery again 51.4% of patients would consider using GLP-1 drugs again 57.1% of GLP-1 patients reported losing at least 20 pounds 98.1% of bariatric surgery patients reported losing at least 20 pounds Median weight loss for bariatric surgery patients was 100 pounds, as opposed to 20 for GLP-1s Average weight loss for bariatric surgery was reported to be 101.2, as opposed to 24.9 for GLP-1 users 93.4% of Patients Would Get Bariatric Surgery Again Out of all patients surveyed, 93.4% said they would get bariatric surgery again

That said, some providers do recommend stepping down the dose gradually rather than stopping all at once, and there are practical reasons for this approach

For HS, it should be viewed as a possible metabolic adjunct, not a replacement for dermatology-led care

They can go through your medical history and come up with a treatment plan that works for you

A highly sophisticated ultrasound instrument with enhanced needle visualization is used for the precise delivery of these cells